What PathnSitu Biotechnologies does
Founded in 2013, PathnSitu Biotechnologies operates in Health Tech offering innovative techniques and quality reagents for the study of carcinoma in situ to improve cancer diagnosis. The company leverages extensive global tissue diagnostics experience from its team of scientific and technical advisors to enhance laboratory efficiency. PathnSitu aims to streamline staining processes and reduce turnaround times for better patient care while maintaining affordability. Recognised for its commitment to quality, it holds several certifications including ISO 9001:2008 and ISO 13485:2003.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about PathnSitu Biotechnologies yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.